Generalisability Box (n = 866)
b
|
c
| | | |
Was the sample in which the HR-PRO instruments was evaluated adequately described? In terms of:
| | | | |
1d
|
median or mean age (with standard deviation or range)?
|
733
|
86
|
865
|
0.36
|
2d
|
distribution of sex?
|
735
|
88
|
863
|
0.38e
|
3
|
important disease characteristics (e.g. severity, status, duration) and description of treatment?
|
746
|
80
|
862
|
0.39f
|
4d
|
setting(s) in which the study was conducted? e.g. general population, primary care or hospital/rehabilitation care
|
735
|
89
|
863
|
0.30e
|
5d
|
countries in which the study was conducted?
|
733
|
90
|
861
|
0.40e
|
6d
|
language in which the HR-PRO instrument was evaluated?
|
733
|
86
|
861
|
0.41e
|
7d
|
Was the method used to select patients adequately described? e.g. convenience, consecutive, or random
|
729
|
81
|
857
|
0.40
|
8
|
Was the percentage of missing responses (response rate) acceptable?
|
724
|
82
|
849
|
0.48
|